Empaphage-L Tablets 5mg+25mg
Empaphage-L Tablets 5mg+25mg combine empagliflozin 25mg (SGLT2 inhibitor) and linagliptin 5mg (DPP-4 inhibitor) for prescription dual-action type 2 diabetes management. Two complementary mechanisms for enhanced glycaemic control when monotherapy is insufficient. Also reduces cardiovascular risk. Prescription required. Available at Derma.pk Pakistan.
Pay in 3 Installments of
Rs.
253
Empaphage-l Tablets 5mg+25mg
Description
Empaphage-L Tablets 5mg+25mg – Empagliflozin + Linagliptin Dual-Action Diabetes Tablets
Empaphage-L Tablets 5mg+25mg combine two prescription antidiabetic agents: empagliflozin 25mg (SGLT2 inhibitor) and linagliptin 5mg (DPP-4 inhibitor). This dual-mechanism combination delivers complementary and synergistic glycaemic control in adults with type 2 diabetes mellitus. Empagliflozin reduces blood glucose by blocking renal glucose reabsorption; linagliptin enhances insulin secretion and reduces glucagon through DPP-4 inhibition. Prescribed when single-agent therapy alone is insufficient.
- Dual action: empagliflozin 25mg (SGLT2 inhibitor) + linagliptin 5mg (DPP-4 inhibitor)
- Complementary glycaemic control through two distinct mechanisms
- Empagliflozin reduces cardiovascular risk in T2DM with established CVD
- Linagliptin is weight-neutral and generally well-tolerated
- Prescription-only combination antidiabetic — requires valid Rx
How to Use Empaphage-L Tablets 5mg+25mg
Take as prescribed by your doctor, typically once daily with or without food. Swallow whole with water. Monitor blood glucose regularly. Maintain prescribed diet and exercise. Contraindicated in severe renal impairment. Do not discontinue without medical guidance.
Shop related products: Empaphage 25mg Tablets | Empaphage 10mg Tablets
Usage & Benefits
- Dual mechanism: empagliflozin 25mg (SGLT2) + linagliptin 5mg (DPP-4)
- Empagliflozin reduces blood glucose by blocking renal glucose reabsorption
- Linagliptin enhances insulin secretion and reduces glucagon levels
- Complementary action provides superior glycaemic control vs monotherapy
- Empagliflozin reduces cardiovascular mortality risk in T2DM
- Linagliptin is renal-dose-independent — suitable across varying renal function
- Prescription-only combination for medically supervised T2DM management
How To Use
1. Take Empaphage-L Tablets 5mg+25mg exactly as prescribed by your doctor.
2. The usual dose is once daily, with or without food.
3. Swallow the tablet whole with water — do not crush, split, or chew.
4. Continue prescribed diet, exercise, and blood glucose monitoring.
5. Do not skip doses or stop without your doctor's guidance.
6. Contraindicated in severe renal impairment, ESRD, or patients on dialysis.
FAQs
What are the active ingredients in Empaphage-L Tablets 5mg+25mg?
Empaphage-L contains empagliflozin 25mg (SGLT2 inhibitor) and linagliptin 5mg (DPP-4 inhibitor) — two different antidiabetic agents with complementary mechanisms for type 2 diabetes control.
Is Empaphage-L a prescription medicine?
Yes. Empaphage-L is a prescription-only combination antidiabetic medicine. A valid prescription from a registered doctor is required.
When is Empaphage-L prescribed instead of single-agent therapy?
Empaphage-L is prescribed when diet, exercise, and monotherapy with either empagliflozin or linagliptin alone do not provide adequate blood sugar control. The combination offers dual-mechanism, synergistic glycaemic management.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
